J1612 — Injection, glucagon (gvoke), 0.01 mg
J1612 is a HCPCS Level II code for injection, glucagon (gvoke), 0.01 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J1612
- Long descriptor
- Injection, glucagon (gvoke), 0.01 mg
- Short descriptor
- Inj glucagon (gvoke) 0.01 mg
- Added
- October 1, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J1612
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1612 is not quite right, the correct code is very often within a few positions of it.
- J1596Injection, glycopyrrolate, 0.1 mg
- J1597Injection, glycopyrrolate (glyrx-pf), 0.1 mg
- J1598Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
- J1599Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
- J1600Injection, gold sodium thiomalate, up to 50 mg
- J1602Injection, golimumab, 1 mg, for intravenous use
- J1610Injection, glucagon hydrochloride, per 1 mg
- J1611Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
- J1620Injection, gonadorelin hydrochloride, per 100 mcgterminated
- J1626Injection, granisetron hydrochloride, 100 mcg
- J1627Injection, granisetron, extended-release, 0.1 mg
- J1628Injection, guselkumab, 1 mg
- J1630Injection, haloperidol, up to 5 mg
- J1631Injection, haloperidol decanoate, per 50 mg
- J1632Injection, brexanolone, 1 mg
- J1640Injection, hemin, 1 mg
Questions about J1612
What is HCPCS code J1612?
J1612 is a HCPCS Level II code for injection, glucagon (gvoke), 0.01 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J1612?
The CMS HCPCS file marks J1612 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J1612 paid under the physician fee schedule?
J1612 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).